The Founder's Recovery Stack: 7 Peptides for Sleep, Cognition, Body Composition

The Protocol: Why This Stack Works

A 35-year-old founder presents with a constellation of metabolic and neuroendocrine dysfunction: poor sleep quality, delayed recovery between training sessions, and cognitive fog that impairs executive function. This isn't lifestyle failure—it's a systemic hormonal cascade problem. Sleep deprivation suppresses GH secretion. Poor recovery indicates low IGF-1 and elevated cortisol. Cognitive decline in high-stress individuals reflects both HPA axis dysregulation and insufficient neuroprotective signaling.

The stack below addresses each mechanism directly, in sequence, over three 30-day phases. The goal isn't pharmaceutical sledgehammering. It's restoring the body's native signaling capacity.

Phase 1: Foundation & HPA Axis Recovery (Days 1–30)

Peptide 1: Sermorelin (GRF 1-29)

Sermorelin is a GHRH analog that stimulates the somatotroph cells of the anterior pituitary to release endogenous growth hormone. It restores natural pulsatile GH secretion rather than replacing it. Dose: 100–200 mcg subcutaneous, typically in the evening to leverage the body's natural nocturnal GH surge.

Why Phase 1? Sleep quality is foundational. GH release is sleep-dependent. Sermorelin begins restoring this signal immediately, improving sleep architecture within 10–14 days for most users. It also lowers cortisol by supporting anabolic signaling (GH is gluconeogenic but cortisol-suppressive in the right context).

Peptide 2: BPC-157 (Body Protection Compound-157)

BPC-157 is a 15-amino-acid synthetic peptide derived from gastric juice. It stabilizes mast cells, improves GI barrier function, upregulates VEGF (vascular endothelial growth factor), and enhances neuroplasticity via BDNF pathways. Dose: 250–500 mcg daily, administered subcutaneously or intranasally.

Why Phase 1? Founders under chronic stress have permeable guts and impaired vagal tone. BPC-157 repairs the mucosal barrier and restores parasympathetic dominance, which directly improves sleep onset and quality. It also accelerates recovery from central fatigue.

Supplementary Synergy: Magnesium Glycinate + Ashwagandha

Magnesium glycinate (400–500 mg, taken 1–2 hours before bed) potentiates GABA signaling and relaxes skeletal muscle. The glycine itself enhances collagen synthesis and sleep quality. Ashwagandha (300–500 mg KSM-66 extract, 2× daily) reduces cortisol by <20% in clinical studies and improves REM sleep latency. Together with sermorelin and BPC-157, these supplements create a permissive environment for sleep restoration.

Phase 2: Recovery & Metabolic Optimization (Days 31–60)

Peptide 3: Ipamorelin

Ipamorelin is a selective GH secretagogue (GHRP analog) that stimulates GH release without elevating prolactin or cortisol. It's safer than GHRP-6 for chronic use. Dose: 200–300 mcg subcutaneous, 2–3× weekly, ideally post-workout.

Why Phase 2? By day 30, sermorelin has re-established baseline GH pulsatility. Ipamorelin amplifies the signal during the recovery window—when muscle protein synthesis is upregulated and intramuscular glycogen repletion is highest. The result: measurably faster recovery, increased work capacity, and higher IGF-1 by day 45.

Peptide 4: TB-500 (Thymosin Beta-4)

TB-500 is a 43-amino-acid peptide that increases actin expression, promoting cellular repair and wound healing at the myocellular level. It also upregulates HIF-1α (hypoxia-inducible factor), improving oxygen utilization. Dose: 2 mg weekly, subcutaneous.

Why Phase 2? TB-500 doesn't directly stimulate hormone release—it enhances tissue recovery. For someone training hard while sleep-deprived, this is critical. It accelerates repair of accumulated micro-damage in skeletal muscle and connective tissue.

Peptide 5: Epithalon (Epitalon)

Epithalon is a tetrapeptide (Ala-Glu-Asp-Gly) that regulates the pineal gland and improves telomerase activity. It lengthens sleep duration, deepens slow-wave sleep, and may extend cellular replicative lifespan. Dose: 10 mg weekly, typically as a single subcutaneous injection.

Why Phase 2? This peptide directly restores pineal function, which has been suppressed by decades of artificial light exposure and high-frequency stress. It also complements sermorelin and ipamorelin by ensuring GH release occurs during deeper, more restorative sleep stages.

Supplementary Synergy: NAC + Vitamin D3/K2 + Methylated B Complex

N-acetylcysteine (600 mg, 2× daily) replenishes glutathione, protecting against oxidative stress from high-dose peptide signaling. Vitamin D3 (4,000–5,000 IU daily) and K2 (90–180 mcg daily) optimize calcium metabolism and support immune resilience. A methylated B-complex (methylcobalamin, methylfolate, pantothenic acid) supports methylation reactions required for neurotransmitter synthesis—dopamine and serotonin production both spike as sleep improves.

Phase 3: Cognitive Enhancement & Sustained Adaptation (Days 61–90)

Peptide 6: Cerebrolysin

Cerebrolysin is a neuropeptide mixture derived from porcine brain tissue. It contains neurotrophic factors that enhance synaptic plasticity, increase BDNF signaling, and improve mitochondrial ATP production in neuronal tissue. Dose: 10 mL intramuscular or intravenous, 3–5× weekly.

Why Phase 3? By day 60, sleep and recovery are restored. Cognitive fog persists because the brain itself requires trophic support to rebuild executive function circuits. Cerebrolysin directly addresses this. Clinical studies show improved working memory and processing speed within 3 weeks.

Peptide 7: Selank (Tuftsin)

Selank is a synthetic heptapeptide analog that reduces anxiety, improves attention, and enhances memory consolidation. It acts as a GABA/glutamate modulator and increases IL-6 signaling. Dose: 250–500 mcg intranasally or subcutaneously, 1–2× daily.

Why Phase 3? At this point, the founder's sleep is normalized, recovery is accelerated, but stress-related cognitive suppression lingers. Selank restores cognitive resilience by rebalancing excitatory and inhibitory neurotransmission, allowing executive function to fully return.

Supplementary Synergy: Omega-3 (EPA/DHA) + Creatine + Zinc

Omega-3 fatty acids (2–3 g combined EPA/DHA daily) are the precursors for neuroprotective metabolites like resolvin D1 and protectin D1. Creatine monohydrate (5 g daily) increases ATP availability in the brain, improving cognitive endurance. Zinc (15–25 mg daily, bound to glycine or picolinate) supports NMDA receptor function and is depleted by chronic stress. These three create a neurochemical foundation for sustained cognitive gains.

Blood Testing Protocol

Before starting (baseline):

Total and free testosterone
IGF-1 (expect <100 ng/mL in sleep-deprived individuals)
Growth hormone (fasting, early morning)
Cortisol (4-point salivary curve: 8 AM, 12 PM, 4 PM, 11 PM)
TSH, free T3, free T4
Complete metabolic panel (CMP) and CBC

At day 30:

IGF-1, cortisol curve, testosterone

At day 60:

Full hormone panel, CMP

At day 90:

Repeat baseline labs

Expected outcomes by day 90:

IGF-1: >200 ng/mL (from <100)
Cortisol nadir (11 PM): <5 nmol/L (from >10)
Total testosterone: +15–20% increase
Sleep efficiency: >85% (from ~70%)
Cognitive processing speed: measurable improvement on computerized tests

Bottom Line

This protocol is not simultaneous polypharmacy. It's sequential restoration of the neuroendocrine hierarchy: sleep first, recovery second, cognition third. Each phase builds on the last. By day 90, the founder's baseline hormonal health is restored, not replaced. The peptides are withdrawn, and the body maintains these improvements because the signaling pathways have been rebooted.

Success requires three things: precise dosing (pharmaceutical-grade compounds only), sequential adherence (no shortcutting phases), and monthly lab monitoring. This isn't a biohack. It's endocrinology.

Disclaimer: This content is for educational purposes only and does not constitute medical advice.